Registration of painkiller users is not necessary, FDA says

06/28/2010 | Bloomberg Businessweek

The FDA recommended that makers of extended-release painkillers should not have to enroll patients or providers in a registration system as part of an effort to restrict the use of long-acting pain drugs. The agency said the process "would be an enormous undertaking with unpredictable effects on patient access."

View Full Article in:

Bloomberg Businessweek

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ